SCHEMBL17551981

SCHEMBL17551981

OC[C@@H]1C[C@H](O)C[C@@H](O)N1

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ QARS1 P47897 1/20 0.38
▸ AGL P35573 2/20 0.31
▸ GBA2 Q9HCG7 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ GBA1 P04062 1/20 0.31
▸ GLA P06280 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13892976 0.76 QARS1 (0.36) QARS1
SCHEMBL26893956 0.74 — —
SCHEMBL2275662 0.74 — —
SCHEMBL18410484 0.74 — —
Hydrochloric Acid SCHEMBL3579781 0.72 — —
SCHEMBL20726333 0.70 QARS1 (0.33) QARS1
SCHEMBL20311013 0.69 — —
SCHEMBL8910466 0.69 — —
SCHEMBL20282958 0.69 — —
SCHEMBL21325848 0.67 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1896083-B1 A METHOD FOR THE TREATMENT OF POMPE DISEASE USING 1-DEOXYNOJIRIMYCIN AND DERIVATIVES AMICUS THERAPEUTICS INC (US) 2016-03-02 — — EP disclosed
Send feedback